Skip to main content

Table 2 The correlation of mRNA expression of Kiss-1 and clinical parameters

From: Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer

Category

 

No.

Median

IQR

p

P a

T/Nb

      
 

Normal

80

97

6-2345

  
 

Tumour

94

35

1-2108

0.3775

 

Paired T/Nb

     
 

Paired normal

68

82

6-2344

  
 

Paired tumour

68

8

0-1855

0.1672

 

Location

      
 

Left colon

22

624

173-1968

  
 

Right colon

28

719

44-2000

0.899

 
 

Transcolonc

2

154

N/A

0.958

 
 

Rectum

22

673

175-2522

0.907

 

Dukes classification

     
 

A

7

5539

848-24856

  
 

B

33

780

104-2272

0.043d

 
 

C

32

611

190-1221

0.015d

 

Tumour stage

     
 

T1

2

8000

N/A

  
 

T2

10

1721

789-10369

1

 
 

T3

40

639

71-1332

0.226

0.0381d

 

T4

18

592

215-1600

0.186

 

Lymph node involvement

     
 

Node 0e

39

872

213-2874

  
 

Node 1e

16

715

67-1428

0.326

 
 

Node 2e

15

609

200-643

0.045d

 

TNM staging

     
 

I

9

2081

814-20038

  
 

II

30

756

122-2473

0.06

 
 

III&IV

32

611

190-1221

0.009d

 

Clinical outcome

     
 

No invasion

50

835

127-2372

  
 

Invasion

26

579

161-948

0.1907

 
 

Disease free

35

759

84-2081

  
 

Incidence

23

635

217-2187

0.8115

 
 

No recurrence

58

735

89-2373

  
 

Local recurrence

7

643

269-3718

0.604

 
 

No metastasis

50

735

84-2522

  
 

Metastasis

19

634.3

213-1463

0.92

 
 

Alive

36

661

86-1876

  
 

Death

22

572

195-1644

0.923

 
  1. aTumour (T), Normal (N). bTransverse colon. c p < 0.05. dNode 0 stands for no node involvement; Node 1 stands for 1 to 3 lymph nodes close to the bowel found to contain cancer cells; Node 2 stands for more than 3 lymph nodes found to contain cancer cells and further than 3cm away from the main tumor in the bowel or the presence of cancer cells in lymph nodes connected to the main blood vessels around the bowel.